54 related articles for article (PubMed ID: 20868569)
1. Genetic association of HLA-A*2601 with ocular Behçet's disease in Japanese patients.
Kaburaki T; Takamoto M; Numaga J; Kawashima H; Araie M; Ohnogi Y; Harihara S; Kuwata S; Takeuchi F
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S39-44. PubMed ID: 20868569
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association analysis reveals the associations of NPHP4, TYW1-AUTS2 and SEMA6D for Behçet's disease and HLA-B*46:01 for its intestinal involvement.
Jung ES; Ellinghaus D; Degenhardt F; Meguro A; Khor SS; Mucha S; Wendorff M; Juzenas S; Mizuki N; Tokunaga K; Kim SW; Lee MG; Schreiber S; Kim WH; Franke A; Cheon JH
Dig Liver Dis; 2024 Jun; 56(6):994-1001. PubMed ID: 37977914
[TBL] [Abstract][Full Text] [Related]
3. Novel genetic variants of HLA gene associated with Thai Behcet's disease (BD) patients using next generation sequencing technology.
Sornsamdang G; Shobana J; Chanprapaph K; Chantratita W; Chotewutmontri S; Limtong P; O-Charoen P; Sukasem C
Sci Rep; 2024 Apr; 14(1):7967. PubMed ID: 38575661
[TBL] [Abstract][Full Text] [Related]
4. Significant association of HLA-A26 with uveitis and gastrointestinal involvement in patients with Behçet's disease in a multicenter study.
Nakajima T; Tsuji H; Inaba R; Saito R; Nishimura K; Morinobu A
Mod Rheumatol; 2024 Mar; ():. PubMed ID: 38482606
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing of Behçet's disease using next-generation sequencing to identify monogenic mimics and HLA-B*51.
Burleigh A; Omoyinmi E; Papadopoulou C; Al-Abadi E; Hong Y; Price-Kuehne F; Moraitis E; Titheradge H; Montesi F; Xu D; Eleftheriou D; Brogan P
Rheumatology (Oxford); 2023 Nov; ():. PubMed ID: 38006337
[TBL] [Abstract][Full Text] [Related]
6. Advances in pathogenesis and treatment of ocular involvement in Behcet's disease.
Lin S; Xu Z; Lin Z; Xie B; Feng J
Front Immunol; 2023; 14():1206959. PubMed ID: 37841268
[TBL] [Abstract][Full Text] [Related]
7. Association between germ-line HLA and immune-related adverse events.
Jiang N; Yu Y; Zhang M; Tang Y; Wu D; Wang S; Fang Y; Zhang Y; Meng L; Li Y; Miao H; Ma P; Huang H; Li N
Front Immunol; 2022; 13():952099. PubMed ID: 36177028
[TBL] [Abstract][Full Text] [Related]
8. Natural LILRB1 D1-D2 variants show frequency differences in populations and bind to HLA class I with various avidities.
Liu F; Cocker ATH; Pugh JL; Djaoud Z; Parham P; Guethlein LA
Immunogenetics; 2022 Dec; 74(6):513-525. PubMed ID: 35562487
[TBL] [Abstract][Full Text] [Related]
9. The Immunogenetics of Behcet's Disease.
Yılmaz MA; Türsen Ü
Adv Exp Med Biol; 2022; 1367():335-347. PubMed ID: 35286701
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings.
Takeuchi M; Mizuki N; Ohno S
Front Immunol; 2021; 12():640473. PubMed ID: 33912164
[TBL] [Abstract][Full Text] [Related]
11. French recommendations for the management of Behçet's disease.
Kone-Paut I; Barete S; Bodaghi B; Deiva K; Desbois AC; Galeotti C; Gaudric J; Kaplanski G; Mahr A; Noel N; Piram M; Tran TA; Wechsler B; Saadoun D;
Orphanet J Rare Dis; 2021 Feb; 16(Suppl 1):352. PubMed ID: 33622338
[TBL] [Abstract][Full Text] [Related]
12. Past and Present Behçet's Disease Animal Models.
Charles J; Castellino FJ; Ploplis VA
Curr Drug Targets; 2020; 21(16):1652-1663. PubMed ID: 32682369
[TBL] [Abstract][Full Text] [Related]
13. Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
Çakar Özdal P
Turk J Ophthalmol; 2020 Jun; 50(3):169-182. PubMed ID: 32631005
[TBL] [Abstract][Full Text] [Related]
14. The association analysis between HLA-A*26 and Behçet's disease.
Nakamura J; Meguro A; Ishii G; Mihara T; Takeuchi M; Mizuki Y; Yuda K; Yamane T; Kawagoe T; Ota M; Mizuki N
Sci Rep; 2019 Mar; 9(1):4426. PubMed ID: 30872678
[TBL] [Abstract][Full Text] [Related]
15. Immune Regulatory Genes Are Major Genetic Factors to Behcet Disease: Systematic Review.
Deng Y; Zhu W; Zhou X
Open Rheumatol J; 2018; 12():70-85. PubMed ID: 30069262
[TBL] [Abstract][Full Text] [Related]
16. Genetic Association of HLA-A*26, -A*31, and -B*51 with Behcet's Disease in Saudi Patients.
Al-Okaily F; Al-Rashidi S; Al-Balawi M; Mustafa M; Arfin M; Al-Asmari A
Clin Med Insights Arthritis Musculoskelet Disord; 2016; 9():167-73. PubMed ID: 27547040
[TBL] [Abstract][Full Text] [Related]
17. The immunogenetics of Behçet's disease: A comprehensive review.
Takeuchi M; Kastner DL; Remmers EF
J Autoimmun; 2015 Nov; 64():137-48. PubMed ID: 26347074
[TBL] [Abstract][Full Text] [Related]
18. Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with Behçet's Disease.
Kongkaew S; Yotmanee P; Rungrotmongkol T; Kaiyawet N; Meeprasert A; Kaburaki T; Noguchi H; Takeuchi F; Kungwan N; Hannongbua S
PLoS One; 2015; 10(9):e0135575. PubMed ID: 26331842
[TBL] [Abstract][Full Text] [Related]
19. Association between the major histocompatibility complex and clinical response to infliximab therapy in patients with Behçet uveitis.
Kuroyanagi K; Sakai T; Kohno H; Okano K; Akiyama G; Aoyagi R; Inaba M; Tsuneoka H
Jpn J Ophthalmol; 2015 Nov; 59(6):401-8. PubMed ID: 26318435
[TBL] [Abstract][Full Text] [Related]
20. Gender and ocular manifestations of connective tissue diseases and systemic vasculitides.
Choudhary MM; Hajj-Ali RA; Lowder CY
J Ophthalmol; 2014; 2014():403042. PubMed ID: 24757559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
